It's finally here! Consensus #ACLF & #cirrhosis organ failure definitions. ⤵️
pubmed.ncbi.nlm.nih.gov/40499736/
Why? We need to speak the same language re #ACLF
How? Multi-country consensus panels
Result? Harmonized definitions &  research agenda @aasldnews.bsky.social @easlnews.bsky.social

Recent study:⬆️ #daptomycin resist w #rifaximin.
But does this impact outcomes in #cirrhosis?
In VA & TriNetX we found no impact of rifaximin on dapt users on
🔑30-day mortality
🔑LT
🔑sepsis dev
🔑linezolid use
✅ @amergastroassn.bsky.social ➡️ pubmed.ncbi.nlm.nih.gov/40122471/ @absteward.bsky.social

Unnecessary #antibiotics: #SBP prophylaxis in #cirrhosis ⬆️ #SBP & other infections! Esp #UTIs w similar🦠
latest from VA & Trinetx ⤵️
pubmed.ncbi.nlm.nih.gov/40062879/
50% of US ❌use SBPProph..should we all follow & ⬇️ #AMR?
@absteward.bsky.social @amcollegegastro.bsky.social @ebtapper.bsky.social

Thanks #CDDW #CLM Chris Rose & Premsyl Bercik for the invite to speak in a beautiful but freezing Quebec city on #HE #microbes & #gutbrainaxis. Excellent joint session with #microbiology & #gi expertise. 🇨🇦 warmth shone thru despite the polar vortex!! @vculiver.bsky.social

Pts w #Hepaticencephalopathy get a raw deal for #Livertransplant. Does MELD3.0 help?
🔑 we need to do more!
In @varesearch.bsky.social #cirrhosis pts @amcollegegastro.bsky.social
🔑inpt HE adds >4-5 MELD3.0 points for 90D & 6-7 for 1Y mortality
🔑HE needs priority!⤵️
pubmed.ncbi.nlm.nih.gov/39836914/

Check out @nytimes.com interview of experts re: #wellness my tip? Coffee for the win!! Liver brain and microbes all benefit from this
Check it out below
www.nytimes.com/interactive/... @vculiver.bsky.social @amcollegegastro.bsky.social @ebtapper.bsky.social @easlnews.bsky.social